Sorrento Therapeutics Inc
SRNE
Market Cap$3.31M
Close$
Share Statistics
| Market cap | $3.31 Million |
|---|---|
| Enterprise Value | $141.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.37 |
| Beta | 0.86 |
| Outstanding Shares | 551,281,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 2.2 |
| Enterprise Value to EBIT | -0.39 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.47 |
| Debt to Equity | -1.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sorrento Therapeutics Inc
CEO: Henry Ji